Compare DERM & CXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DERM | CXE |
|---|---|---|
| Founded | 2014 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.3M | 117.6M |
| IPO Year | 2021 | N/A |
| Metric | DERM | CXE |
|---|---|---|
| Price | $5.02 | $3.68 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $12.67 | N/A |
| AVG Volume (30 Days) | ★ 187.9K | 74.1K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.36% |
| EPS Growth | ★ 34.72 | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | ★ $61,858,000.00 | N/A |
| Revenue This Year | $39.72 | N/A |
| Revenue Next Year | $63.24 | N/A |
| P/E Ratio | ★ N/A | $52.71 |
| Revenue Growth | ★ 10.20 | N/A |
| 52 Week Low | $4.31 | $3.40 |
| 52 Week High | $9.56 | $3.88 |
| Indicator | DERM | CXE |
|---|---|---|
| Relative Strength Index (RSI) | 38.37 | 37.30 |
| Support Level | $4.31 | $3.66 |
| Resistance Level | $5.60 | $3.76 |
| Average True Range (ATR) | 0.26 | 0.03 |
| MACD | 0.10 | -0.00 |
| Stochastic Oscillator | 15.71 | 19.23 |
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
Mfs High Income Municipal Trust is a United States-based diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in tax-exempt bonds and tax-exempt notes. The company's investment portfolio has shares from the industry Healthcare, Airports, and Secondary Schools.